felin
immunodefici
viru
fiv
infect
focu
sever
studi
viru
exhibit
genet
pathogen
characterist
similar
human
immunodefici
viru
hiv
fiv
caus
acquir
immunodefici
syndrom
aid
cat
nevertheless
larg
fraction
infect
cat
remain
asymptomat
throughout
life
despit
persist
chronic
infect
slow
diseas
progress
may
due
presenc
factor
involv
natur
resist
infect
immun
respons
mount
anim
well
due
adapt
viru
host
therefor
studi
virushost
interact
essenti
understand
differ
pattern
diseas
cours
viru
persist
host
help
develop
effect
vaccin
perhap
cure
fiv
hiv
infect
felin
immunodefici
viru
fiv
initi
isol
domest
cat
exhibit
sign
immunodefici
seroneg
felin
leukaemia
viru
felv
fiv
belong
famili
retrovirida
subfamili
orthoretrovirina
genu
lentiviru
exhibit
complex
genom
organis
includ
structur
gene
gag
pol
env
well
sever
gene
encod
nonstructur
protein
end
provir
dna
integr
host
cell
chromosom
compris
long
termin
repeat
ltr
repeat
region
contain
inform
start
termin
transcript
genom
organis
pathogenesi
fiv
similar
human
immunodefici
viru
hiv
fiv
wide
use
experiment
model
studi
immunopathogenesi
virushost
interact
develop
vaccin
antiretrovir
therapi
fiv
present
worldwid
classifi
five
wellcharacteris
subtyp
ae
preval
fiv
vari
depend
health
statu
investig
cat
preval
fiv
influenc
anim
behaviour
freerang
male
cat
area
high
popul
densiti
constitut
risk
group
mainli
greater
exposur
bite
main
path
diseas
transmiss
territori
demarc
fight
infect
cat
exhibit
specif
clinic
sign
anim
remain
asymptomat
throughout
life
fiv
infect
caus
progress
immunosuppress
result
develop
acquir
immunodefici
syndrom
aid
cat
similar
human
hiv
infect
increas
suscept
secondari
opportunist
infect
concomitantli
fiv
also
caus
immunostimul
result
immunemedi
diseas
fiv
infect
one
import
infecti
diseas
cat
caus
persist
infect
aim
present
review
discuss
virushost
interact
fiv
infect
better
understand
immunopathogenesi
diseas
particularli
immun
system
dysfunct
addit
present
review
seek
establish
presenc
factor
involv
natur
resist
fiv
infect
similar
discov
hivexpos
seroneg
human
follow
infect
viral
replic
occur
dendrit
cell
macrophag
lymphocyt
mark
viraemia
usual
detect
second
week
postinfect
pi
peak
week
viru
spread
across
entir
organ
initi
stage
acut
phase
anim
may
exhibit
mild
moder
clinic
sign
fever
transient
generalis
lymphadenopathi
anorexia
lethargi
gagspecif
cytotox
lymphocyt
may
detect
earli
second
week
pi
prior
seroconvers
two
eight
week
infect
specif
antibodi
surfac
su
transmembran
tm
protein
env
gene
capsid
ca
matrix
protein
gag
gene
might
identifi
despit
develop
cellular
humor
immun
respons
anim
unabl
elimin
viru
lead
establish
persist
fiv
infect
nevertheless
immun
respons
reduc
circul
viral
load
defin
onset
asymptomat
stage
infect
cat
remain
stage
mani
year
even
throughout
life
clinic
sign
howev
progress
immunodefici
reduct
number
lymphocyt
invers
ratio
final
proport
fivposit
cat
reach
second
stage
termin
phase
correl
generalis
lymphadenopathi
preaid
aid
stage
hiv
infect
phase
characteris
sever
immunosuppress
consequ
reduct
circul
antibodi
allow
viral
load
increas
develop
diseas
caus
opportunist
secondari
chronic
infect
neoplasia
neurolog
disord
despit
progress
immunodefici
cours
diseas
depend
virushost
interact
explain
fraction
anim
develop
termin
phase
cell
tropism
pathogenesi
viral
diseas
determin
specif
interact
viral
surfac
protein
host
cell
receptor
similar
hiv
infect
infect
fiv
requir
initi
interact
primari
receptor
subsequ
bind
coreceptor
case
hiv
infect
surfac
glycoprotein
interact
receptor
express
surfac
lymphocyt
result
conform
chang
expos
coreceptor
bind
site
therebi
allow
bind
chemokin
receptor
interact
coreceptor
induc
conform
chang
hiv
transmembran
glycoprotein
expos
fusion
peptid
thu
allow
fusion
viral
envelop
cell
membran
conform
chang
envelop
protein
import
mechan
viral
escap
conserv
region
surfac
protein
target
neutralis
antibodi
expos
prior
bind
receptor
coreceptor
contrast
hiv
fiv
use
instead
primari
receptor
also
known
member
tumour
necrosi
factor
nerv
growth
factor
receptor
superfamili
larg
fraction
fiv
primari
strain
isol
infect
anim
like
transmiss
virus
requir
initi
bind
receptor
subsequ
bind
chemokin
receptor
product
infect
howev
cultureadapt
fiv
strain
use
receptor
abl
interact
directli
coreceptor
interact
fiv
surfac
protein
lead
structur
chang
expos
bind
site
coreceptor
bind
coreceptor
induc
exposur
serpentin
region
fiv
transmembran
protein
bind
cell
membran
therebi
origin
hairpin
structur
allow
viral
fusion
entri
interact
also
induc
exposur
epitop
target
neutralis
antibodi
although
region
princip
immunodomin
domain
fiv
antibodi
produc
exhibit
low
neutralis
activ
howev
upon
bind
solubl
de
persev
et
al
observ
monoclon
antibodi
surfac
protein
inhibit
fiv
infect
vitro
denot
viral
escap
mechan
infect
addit
mechan
viral
protect
host
immun
respons
bind
viru
cell
surfac
receptor
coreceptor
also
account
differenti
cell
tropism
occur
throughout
cours
diseas
case
hiv
infect
bind
via
receptor
allow
entri
lymphocyt
howev
main
viral
strain
found
earli
stage
infect
use
coreceptor
express
activ
memori
lymphocyt
wherea
strain
isol
later
stage
tend
use
coreceptor
case
fiv
infect
viral
strain
test
date
interact
coreceptor
cat
highli
express
activ
cell
b
cell
monocyt
nevertheless
need
interact
primari
receptor
abundantli
express
activ
lymphocyt
constrain
initi
infect
consequ
result
deplet
tcell
subgroup
play
vital
role
develop
antigenspecif
cellular
immun
respons
therefor
although
virus
use
differ
entri
receptor
initi
target
fiv
hiv
activ
lymphocyt
howev
progress
infect
host
immun
respons
exert
posit
select
pressur
viru
high
error
rate
revers
transcriptas
enzym
involv
retrovir
replic
lead
mutat
result
gener
wide
varieti
differ
viral
genom
within
singl
individu
quasispeci
allow
small
chang
surfac
protein
alter
recognit
immun
system
antigen
drift
kraas
et
al
found
greater
accumul
mutat
fiv
env
gene
amongst
cat
diagnos
late
infect
week
pi
compar
anim
acut
infect
week
pi
mutat
mainli
found
glycosyl
region
addit
mechan
use
virus
evad
immun
system
addit
singl
mutat
involv
loss
glycosyl
site
might
give
rise
mutant
less
depend
receptor
similar
cultureadapt
fiv
prototyp
viral
variant
bind
directli
coreceptor
like
suscept
neutralis
antibodi
thu
presenc
virus
circul
asymptomat
phase
must
transient
howev
anim
reach
termin
phase
characteris
sever
immunosuppress
virus
begin
circul
increas
number
infect
cell
includ
lymphocyt
b
lymphocyt
astrocyt
mention
cellular
humor
antivir
immun
respons
occur
acut
phase
infect
reduc
viral
load
howev
infect
persist
result
viral
evas
mechan
eg
glycosyl
viral
envelop
protein
camouflag
immunodomin
epitop
structur
chang
envelop
glycoprotein
bind
host
cell
antigen
drift
immun
dysfunct
occur
infect
progress
fiv
infect
two
oppos
event
occur
result
immun
dysfunct
immunosuppress
hyperactiv
immun
system
summari
event
promot
immun
dysfunct
shown
fig
immunosuppress
caus
fiv
infect
manifest
loss
respons
viral
antigen
loss
respons
mitogen
inabl
launch
primari
immun
respons
secondari
pathogen
torten
et
al
observ
togeth
progress
diseas
month
pi
infect
cat
exhibit
reduct
respons
tdepend
immunogen
adequ
respons
tindepend
immunogen
addit
research
observ
reduct
lymphocyt
prolifer
induc
mitogen
infect
cat
alter
cytokin
product
immun
anergi
apoptosi
hyperactiv
regulatori
cell
mechan
might
explain
immun
system
dysfunct
although
sever
studi
quantifi
cytokin
fivinfect
cat
profil
cytokin
alter
yet
well
establish
tabl
cytokin
alter
like
relat
infect
stage
especi
relat
reduct
lymphocyt
invers
ratio
well
differ
method
use
quantif
protein
transcript
lawrenc
et
al
observ
signific
increas
product
tumour
necrosi
factor
alpha
peripher
blood
mononuclear
cell
pbmc
respons
mitogen
concanavalin
cona
pokewe
mitogen
pwm
fivposit
cat
without
sign
immunosuppress
addit
signific
reduct
observ
symptomat
anim
also
exhibit
reduc
lymphocyt
prolifer
respons
mitogen
increas
bioactiv
observ
alveolar
macrophag
four
week
pi
week
pi
invers
ratio
studi
also
observ
increas
express
interferongamma
increas
express
reduc
express
observ
infect
cat
invers
ratio
week
pi
fivinfect
cat
exhibit
primari
immun
respons
secondari
infect
either
toxoplasma
gondii
listeria
monocytogen
fivand
gondiicoinfect
anim
exhibit
increas
express
infect
secondari
pathogen
high
product
suppress
product
cytokin
explain
inabl
contain
infect
gondii
dean
et
al
observ
fivposit
cat
especi
anim
chronic
infect
invers
ratio
exhibit
higher
number
colonyform
unit
l
monocytogen
lymph
node
addit
innat
immun
respons
cat
chronic
infect
unabl
contain
secondari
infect
four
day
inocul
unlik
anim
acut
infect
fivneg
cat
reduct
respons
infect
l
monocytogen
might
due
increas
express
inhibit
product
macrophag
contrast
levi
et
al
dean
et
al
observ
reduct
level
like
anim
latter
studi
exhibit
alter
ratio
nevertheless
studi
observ
increas
ratio
explain
defici
respons
secondari
pathogen
stimul
product
suppress
product
dendrit
cell
therefor
import
chang
cytokin
product
result
defici
respons
secondari
pathogen
fiv
hiv
infect
associ
progress
loss
tcell
function
caus
suppress
product
increas
program
cell
death
apoptosi
cell
lymph
node
immun
anergi
function
inactiv
b
lymphocyt
follow
antigen
stimul
due
inadequ
amount
costimulatori
molecul
eg
antigenpres
cell
presenc
inhibitori
cytotox
lymphocyteassoci
antigen
receptor
bind
molecul
receptor
express
lymphocyt
stimul
releas
consequ
clonal
expans
need
mount
effect
immun
respons
wherea
bind
receptor
suppress
releas
thu
termin
immun
respons
addit
antigen
recognit
induc
product
proapoptot
protein
activ
protein
neutralis
antiapoptot
protein
normal
respons
microorgan
guiot
et
al
observ
fivinfect
cat
exhibit
increas
apoptosi
affect
lymphocyt
type
lymphocyt
b
lymphocyt
natur
killer
nk
cell
increas
apoptosi
directli
correl
increas
anim
age
durat
infect
reduct
number
cell
increas
apoptosi
cell
lymph
node
blood
fivposit
cat
might
relat
increas
level
cell
phenotyp
increas
cell
observ
anim
acut
infect
month
asymptomat
anim
year
mainli
anim
termin
infect
year
exhibit
chronic
secondari
oral
respiratori
infect
case
presenc
bcell
lymphoma
necropsi
chronic
activ
cell
coexpress
possibl
tt
interact
mediat
bind
receptor
induc
bidirect
suppress
result
anergi
apoptosi
therefor
mechan
caus
immunosuppress
progress
loss
cell
prematur
termin
immun
respons
pathogen
regulatori
treg
cell
mostli
cell
express
high
level
alpha
chain
receptor
function
regul
activ
cell
treg
cell
depend
transcript
factor
maintain
function
produc
cytokin
tumour
growth
factor
beta
block
activ
lymphocyt
macrophag
two
differ
type
treg
cell
thymusgener
natur
treg
cell
relat
suppress
autoimmun
cell
mainten
toler
selfantigen
adapt
induc
treg
cell
regul
respons
cell
pathogen
eg
bacteria
fungi
intracellular
parasit
virus
activ
peripher
lymphoid
tissu
function
induc
treg
cell
avoid
tissu
damag
caus
excess
inflamm
respons
pathogen
howev
certain
pathogen
modul
activ
treg
cell
thu
caus
persist
chronic
infect
mexa
et
al
show
treg
cell
target
acut
fiv
infect
sinc
cell
exhibit
high
viral
mrna
level
two
week
infect
correl
peak
viraemia
establish
persist
chronic
infect
may
relat
infect
cell
cell
activ
acut
infect
presenc
transcript
factor
suppress
product
thu
inhibit
antivir
respons
helper
cell
cat
cell
unabl
prolifer
respons
antigen
mitot
stimul
due
lack
product
exhibit
abil
suppress
prolifer
cell
activ
addit
diseas
progress
treg
cell
act
reservoir
infect
viru
might
replic
low
rate
without
becom
target
immun
respons
cell
exhibit
anerg
characterist
although
cat
chronic
fiv
infect
exhibit
proport
cell
fivneg
anim
cell
fivposit
cat
exhibit
greater
express
molecul
lymph
node
blood
well
greater
express
lymph
node
express
molecul
explain
immunosuppress
mechan
associ
treg
cell
activ
fiv
progress
diseas
addit
progress
immunosuppress
fivposit
cat
also
exhibit
mark
hyperactiv
b
cell
total
protein
level
increas
fivinfect
cat
due
increas
gamma
globulin
one
studi
two
fivposit
cat
bcell
lymphoma
exhibit
increas
b
lymphocyt
increas
igg
begin
end
followup
period
correspond
week
pi
progress
increas
iga
takano
et
al
also
observ
higher
globulin
level
fivposit
cat
termin
phase
compar
anim
asymptomat
phase
fivneg
increas
level
b
cell
surfac
immunoglobulin
sig
neg
repres
cell
differenti
antibodi
product
observ
asymptomat
cat
evid
anim
termin
phase
suggest
find
might
relat
emerg
immunosuppress
sign
activ
b
lymphocyt
correspond
polyclon
nonvirusspecif
activ
antibodi
heterolog
nonvir
antigen
detect
six
eight
week
infect
remain
end
studi
week
pi
exhibit
crossreact
fiv
viral
recombin
antigen
furthermor
neither
stimul
b
lymphocyt
hypergammaglobulinemia
caus
coinfect
pathogen
studi
use
specif
pathogen
free
spf
anim
experiment
infect
fiv
therefor
hyperactiv
caus
fiv
respons
appear
immunemedi
diseas
chronic
gingivitisstomat
glomerulonephr
myeloprolif
neoplasm
lymphoma
stimul
cell
start
acut
phase
fiv
infect
continu
throughout
diseas
progress
increas
number
activ
cell
low
suggest
cell
replac
activ
cell
fiv
infect
phenomenon
occur
cell
reduc
express
cours
infect
review
addit
mention
increas
express
molecul
activ
cell
might
alter
host
immun
respons
tompkin
tompkin
suggest
fiv
infect
activ
treg
cell
activ
treg
cell
inhibit
product
product
thu
reduc
immun
respons
fiv
induct
anergi
apoptosi
allow
continu
viral
replic
chronic
antigenaemia
turn
chronic
antigenaemia
caus
hyperactiv
cell
treg
cell
result
anergi
apoptosi
due
activ
treg
cell
inappropri
tt
cell
interact
due
bind
express
larger
amount
activ
cell
uncontrol
hyperactiv
immun
system
caus
progress
immunosuppress
reduct
immun
respons
secondari
infect
major
effort
devot
recent
year
discoveri
novel
altern
treatment
perhap
even
cure
hiv
infect
purpos
mani
studi
seek
understand
factor
involv
natur
resist
infect
occur
individu
despit
histori
frequent
sexual
parenter
vertic
exposur
viru
exhibit
serolog
evid
infect
sign
immunodefici
highrisk
expos
seroneg
esn
individu
seem
genet
immunolog
factor
reduc
suscept
infect
although
singl
factor
individu
may
account
characterist
amongst
genet
factor
involv
slow
progress
aid
resist
hiv
infect
follow
identifi
allel
human
leucocyt
antigen
hla
presenc
activ
absenc
inhibitor
gene
encod
kir
killer
immunoglobulinlik
receptor
molecul
genet
polymorph
chemokin
rant
regul
activ
normal
tcell
express
secret
macrophag
inflammatori
protein
mip
receptor
amongst
alter
delet
base
pair
gene
encod
receptor
strongli
correl
resist
hiv
infect
dean
et
al
observ
approxim
studi
popul
n
includ
healthi
control
esn
individu
hivposit
individu
without
sign
aid
allel
mutat
caus
chang
read
frame
amino
acid
gener
nonfunct
protein
prematur
termin
codon
individu
homozyg
allel
strongli
protect
hiv
infect
individu
lack
function
coreceptor
cell
surfac
homozyg
individu
esn
individu
wherea
none
amongst
hivposit
individu
exhibit
genotyp
addit
heterozyg
individu
exhibit
degre
resist
infect
infect
viral
load
lower
progress
aid
slower
compar
observ
homozyg
individu
still
evid
mutat
fiv
receptor
confer
natur
resist
infect
cat
current
follow
known
vitro
infect
fiv
decreas
larg
fraction
strain
use
felinehuman
hybrid
receptor
human
receptor
function
fiv
entri
mutat
human
coreceptor
prevent
vitro
entri
fiv
nevertheless
although
delet
coreceptor
gene
grant
high
natur
resist
hiv
infect
mutat
found
esn
individu
therefor
factor
might
also
involv
host
innat
immun
contribut
protect
hiv
infect
mainli
activ
nk
cell
larg
product
addit
increas
product
eg
cc
chemokin
ligand
ccl
rant
stromal
cellderiv
peroxiredoxin
ii
cell
antivir
factor
caf
nk
cell
stimulatori
factor
b
cytokin
involv
product
acutephas
protein
defensin
ribonucleas
associ
protect
effect
revis
innat
immun
respons
mediat
cellular
restrict
factor
apolipoprotein
b
mrnaedit
catalyt
polypeptid
tripartit
motif
protein
tetherin
inhibit
viral
replic
retrovirus
thu
block
establish
infect
viru
enter
host
cell
deamin
cytidin
residu
rna
singlestrand
dna
therebi
convert
cytosin
c
uracil
u
thymin
alter
encod
viral
protein
accord
recent
observ
human
exposur
hiv
increas
express
esn
individu
exhibit
higher
express
protein
compar
nonexpos
individu
addit
reduc
suscept
hiv
infect
vitro
cat
action
investig
three
exogen
felin
retrovirus
fiv
felv
felin
syncytiumform
viru
fesfv
differ
first
two
virus
consid
nonpathogen
natur
felv
exhibit
reduc
infect
vitro
protein
present
might
explain
occurr
abort
regress
infect
cat
contact
viru
felv
belong
genu
gammaretroviru
accessori
gene
vif
bet
found
speci
belong
genera
lentiviru
spumaviru
respect
associ
inactiv
except
equin
infecti
anaemia
viru
eiav
lentiviru
lack
vif
gene
exhibit
resist
felin
sever
studi
shown
retrovirus
inhibit
action
nonsuscept
speci
explain
host
specif
enabl
therapeut
use
although
exhibit
antivir
effect
virus
mechan
prevent
action
protein
natur
host
caus
persist
infect
true
tetherin
exert
antivir
action
prevent
releas
viral
particl
dietrich
et
al
show
releas
fiv
particl
inhibit
transient
express
felin
tetherin
howev
fiv
replic
decreas
express
tetherin
stabl
probabl
occur
natur
infect
furthermor
celltocel
spread
viru
facilit
increas
syncytium
format
accord
studi
felin
truncat
exhibit
antiretrovir
effect
therefor
investig
restrict
factor
especi
import
prevent
treatment
infect
warrant
ortholog
restrict
factor
shown
inhibit
infect
retrovirus
although
acquir
immun
cellular
humor
play
crucial
role
resist
hiv
infect
yet
consensu
mechan
truli
protect
regard
cellular
immun
respons
esn
individu
report
indic
strong
antihiv
respons
noncytotox
cell
recognit
differ
epitop
compar
seroposit
individu
greater
respons
characteris
increas
product
reduc
product
nevertheless
low
lymphocyt
activ
also
shown
reduc
suscept
hiv
infect
lymphocyt
activ
need
viral
replic
associ
pathogenesi
diseas
resist
infect
might
relat
humor
immun
respons
mainli
product
antihiv
immunoglobulin
iga
present
cervicovagin
secret
saliva
colostrum
serum
presenc
autoantibodi
receptor
esn
individu
cat
antibodi
observ
fivposit
anim
wherea
antibodi
present
spf
anim
n
diseas
cat
infect
felin
herpesviru
fhv
felin
coronaviru
fcov
felv
fivneg
addit
cat
antibodi
exhibit
lower
viral
load
better
state
health
indic
import
antibodi
progress
diseas
abil
anim
develop
immun
respons
suffici
robust
reduc
fiv
viral
load
although
unabl
extinguish
fiv
infect
may
reflect
import
factor
reduc
speed
diseas
progress
howev
factor
might
also
increas
select
pressur
induc
accumul
greater
number
mutat
throughout
cours
infect
viru
greater
need
adapt
surviv
host
addit
earli
reduct
number
lymphocyt
consequ
decreas
ratio
correl
emerg
immunosuppress
sign
might
relat
presenc
viru
mutat
favour
escap
occur
cat
unabl
develop
respons
restrict
viral
replic
studi
examin
presenc
factor
involv
natur
resist
fiv
infect
cat
identif
factor
may
contribut
better
understand
variou
pattern
diseas
progress
help
develop
fivhiv
cure
complex
virushost
interact
particularli
mechan
viral
persist
justifi
difficulti
develop
effect
vaccin
treatment
therefor
much
interact
must
still
investig
full
understand
fiv
infect
cat
hiv
infect
human
